Detalhe da pesquisa
1.
Perioperative dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin in muscle-invasive bladder cancer (VESPER): survival endpoints at 5 years in an open-label, randomised, phase 3 study.
Lancet Oncol
; 25(2): 255-264, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-38142702
2.
Impact of Divergent Differentiation and/or Histological Subtype of Urothelial Carcinoma on Patient Outcomes in the GETUG-AFU V05 VESPER Trial.
J Urol
; 211(4): 564-574, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38153961
3.
Prognostic value of programmed death ligand-1 and programmed death-1 expression in patients with upper tract urothelial carcinoma.
BJU Int
; 132(5): 581-590, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37488983
4.
Evaluation of the efficacy of sacral neuromodulation in the treatment of voiding dysfunction after endometriosis surgery.
Prog Urol
; 33(17): 1073-1082, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37951811
5.
Observation vs. early drainage for grade IV blunt renal trauma: a multicenter study.
World J Urol
; 39(3): 963-969, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-32447442
6.
Long survival of patients with metastatic clear cell renal cell carcinoma. Results of real life study of 344 patients.
Int J Cancer
; 146(6): 1643-1651, 2020 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-31318983
7.
Clinical interest of PD-L1 immuno-histochemistry expression as a predictive factor of Bacillus Calmette Guerin (BCG) efficacy in refractory high-risk non-muscle-invasive bladder cancer (NMIBC).
World J Urol
; 38(6): 1517-1524, 2020 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-31486884
8.
Perioperative chemotherapy in bladder cancer: the more cisplatin, the best survival?
World J Urol
; 42(1): 140, 2024 Mar 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38478108
9.
Safety and efficacy of temsirolimus as second line treatment for patients with recurrent bladder cancer.
BMC Cancer
; 18(1): 194, 2018 02 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-29454321
10.
The maximum detrusor pressure as a predictive factor of success after sphincterotomy in detrusor-sphincter dyssynergia.
Neurourol Urodyn
; 37(8): 2758-2762, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30203509
11.
Final results of the phase III URO-BCG 4 multicenter study: efficacy and tolerance of one-third dose BCG maintenance in nonmuscle invasive bladder cancer.
Anticancer Drugs
; 28(3): 335-340, 2017 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-27902496
12.
Diagnostic performance of contrast-enhanced ultrasonography and magnetic resonance imaging for the assessment of complex renal cysts: A prospective study.
Int J Urol
; 24(3): 184-189, 2017 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-28147450
13.
The subclassification of papillary renal cell carcinoma does not affect oncological outcomes after nephron sparing surgery.
World J Urol
; 34(3): 347-52, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-26149352
14.
Post-chemotherapy retroperitoneal teratoma in nonseminomatous germ cell tumors: Do predictive factors exist? Results from a national multicenter study.
J Surg Oncol
; 114(8): 992-996, 2016 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-27859263
15.
Morbidity-mortality conference for adverse events associated with totally implanted venous access for cancer chemotherapy.
Support Care Cancer
; 24(4): 1857-63, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-26454864
16.
Baseline chronic kidney disease is associated with toxicity and survival in patients treated with targeted therapies for metastatic renal cell carcinoma.
Anticancer Drugs
; 26(8): 866-71, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26020808
17.
Prostate cancer incidence on cystoprostatectomy specimens is directly linked to age: results from a multicentre study.
BJU Int
; 115(1): 87-93, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24825727
18.
Are warm ischemia and ischemia time still predictive factors of poor renal function after partial nephrectomy in the setting of elective indication?
World J Urol
; 33(1): 11-5, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24700310
19.
Efficacy and tolerance of one-third full dose bacillus Calmette-Guérin maintenance therapy every 3 months or 6 months: two-year results of URO-BCG-4 multicenter study.
Int J Urol
; 22(1): 53-60, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25256813
20.
Clinicopathological characteristics of incidental prostate cancer discovered from radical cystoprostatectomy specimen: a multicenter French study.
Ann Surg Oncol
; 21(2): 684-90, 2014 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-24170436